Common Contracts
1 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • March 31st, 2020
Amendment #2to Clinical Trial Agreement Protocol No. RPC01-3202 Dodatok č. 2k Dohode o klinickom skúšaní Protokol č. RPC01-3202 This amendment (“Amendment”) is made by and between: Tento dodatok („dodatok“) sa uzaviera medzi: Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland, having its principal office at Rue du Pré-Jorat 14, 2108 Couvet, Switzerland (the “Sponsor”) represented based on a Power of Attorney for the purposes of negotiating and signing this Amendment by PSI CRO Slovakia s. r. o., with offices at Krasovskeho 3742/13, 851 01 Bratislava, Slovak Republic, IN: 43 800 807, VAT IN: SK 2022515231, registered in Business Register, Provincial Court Bratislava I, Section Sro, Folio 49073/B, represented by Petr Vaculik, Petra Halaskova and by Petr Sedlak spoločnosťou Celgene International II Sàrl, spoločnosť s ručením obmedzeným, organizovaná podľa švajčiarskych zákonov, so sídlom na adrese Rue du Pré-Jorat 14, 2108 Couvet, Švajčiarsk
